FDA panel to discuss authorizing booster dose for Moderna COVID-19 vaccine

An advisory committee for the Food and Drug Administration will meet for two days beginning on Thursday to evaluate requests from Johnson & Johnson and Moderna to authorize booster doses for Americans.